Literature DB >> 28145101

Typing and copy number determination for HLA-DRB3, -DRB4 and -DRB5 from next-generation sequencing data.

Y Zhang1,2,3, Y Song2,3, H Cao2,3, X Mo2,3,4, H Yang2,5, J Wang2,5, Z Lu1, T Zhang2,3.   

Abstract

BACKGROUND: HLA-DRB3, DRB4 and DRB5 (DRB3/4/5) are paralogues of HLA-DRB1. They have important roles in transplantation and have been reported to be related to many diseases. HLA typing methods for DRB3/4/5 based on NGS data have many limitations now, such as need of polymerase chain reaction (PCR) or low accuracy.
MATERIALS AND METHODS: We present a HLA typing method for DRB3/4/5 based on read mapping and haplotype assembly from NGS data. Also, copy number of DRB3/4/5 is determined by a k-means clustering method according to ratio of sequencing depth between DRB3/4/5 and DRB1.
RESULTS: We achieved 100%, 100%, 100% accuracy on simulated data and 95.88%, 98.89%, 99.34% accuracy on MHC capture Illumina sequencing data at 4-digit resolution with 30-fold coverage for DRB3/4/5 separately. We also explored the DRB3/4/5 profiles in five continental populations through low coverage WGS data generated by the 1000 Genome Project. We found that frequency of DRB4 in African were significantly lower than that in all other populations.
CONCLUSION: Our method for DRB3/4/5 typing has high accuracy. It is a good supplement to regular HLA typing and could help in disease studies, medical applications and human population diversity studies.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990DRB3zzm321990; zzm321990DRB4zzm321990; zzm321990DRB5zzm321990; zzm321990HLA typing; zzm321990NGSzzm321990; copy number

Mesh:

Substances:

Year:  2017        PMID: 28145101     DOI: 10.1111/tan.12966

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  1 in total

1.  AltHapAlignR: improved accuracy of RNA-seq analyses through the use of alternative haplotypes.

Authors:  Wanseon Lee; Katharine Plant; Peter Humburg; Julian C Knight
Journal:  Bioinformatics       Date:  2018-07-15       Impact factor: 6.937

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.